Elsevier Announces Current Opinion Conference on Cellular Host-Pathogen Interactions
Amsterdam, 4 March 2010 – Elsevier, the world-leading publisher of scientific, technical and medical information products and services announced today that the prestigious journal Current Opinion in Cell Biology will host a Cellular Host-Pathogen Interactions Conference, in Amsterdam, The Netherlands, on 5-7 September 2010.
This conference is the first in a new and exciting series of conferences sponsored by the timely and popular Current Opinion journals, and will showcase research to the leading scientists in the field, including the influential Current Opinion editors. These conferences will provide a new level of direct interaction between the leaders in the scientific field and the attending delegates. Emphasis will be placed on the latest unpublished results, extended discussion periods and direct interactions with leaders in the field. Each conference is designed to facilitate extended discussion periods with dedicated networking sessions.
Keynote speakers drawn from the world’s best scientists, will provide an opportunity for scientific researchers and clinicians in the fields of molecular and clinical research to meet and discuss new research in the field, including topics such as pathogen invasion, adaptation, host defense, pathogen life cycle and immune system response.
“This conference is a unique opportunity to bring together experts in diverse fields, to explain the basic mechanisms that have been elucidated through studies of individual pathogens”, said co-chairs Graham Warren and Tom Misteli, Editors-in-Chief of Current Opinion in Cell Biology. “Collectively we hope that, by bringing them all together in a single conference, we will shed light on different works, to the benefit of all”.
For more information visit the conference website at http://conferences.current-opinion.com/
# # #
About the Elsevier Current Opinion titlesThe Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. “Elsevier’s Current Opinion journals comprise of 11 leading titles in life sciences and adjacent fields. They are comprehensive, systematic, authoritative, scholarly and good for teaching.” said Carl Schwarz, Publishing Director in Life Sciences. By consistently covering recent scientific developments, the journals are an indispensible source for scientists.
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com
+31 20 485 3345